Novo Nordisk’s GLP-1 agonist Ozempic has shown efficacy in yet another indication, achieving a 24% reduction in kidney disease-related events in people with type 2 diabetes and chronic kidney disease ...
SINGAPORE - Private organisations that have not phased out the use of NRIC numbers for authentication will risk breaching the Personal Data Protection Act (PDPA) from Jan 1, 2027. In a statement on ...
All private organisations will have to stop using NRIC numbers for authentication by the end of the year, said the Infocomm Media Development Authority (IMDA). In a press release on Monday (Feb 2), ...
Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Amy is an ACA and the CEO and founder of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results